Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

13 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Therapeutic potential of breakers of advanced glycation end product-protein crosslinks.
Vasan S, Foiles P, Founds H. Vasan S, et al. Among authors: founds h. Arch Biochem Biophys. 2003 Nov 1;419(1):89-96. doi: 10.1016/ Arch Biochem Biophys. 2003. PMID: 14568012 Review.
The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes.
Forbes JM, Thallas V, Thomas MC, Founds HW, Burns WC, Jerums G, Cooper ME. Forbes JM, et al. Among authors: founds hw. FASEB J. 2003 Sep;17(12):1762-4. doi: 10.1096/fj.02-1102fje. Epub 2003 Jul 18. FASEB J. 2003. PMID: 12958202
Formation of plasma advanced glycosylation end products (AGEs) has no influence on plasma viscosity.
Mellinghoff AC, Reininger AJ, Wuerth JP, Founds HW, Landgraf R, Hepp KD. Mellinghoff AC, et al. Among authors: founds hw. Diabet Med. 1997 Oct;14(10):832-6. doi: 10.1002/(SICI)1096-9136(199710)14:10<832::AID-DIA492>3.0.CO;2-9. Diabet Med. 1997. PMID: 9371474
Standardizing the immunological measurement of advanced glycation endproducts using normal human serum.
Mitsuhashi T, Vlassara H, Founds HW, Li YM. Mitsuhashi T, et al. Among authors: founds hw. J Immunol Methods. 1997 Aug 22;207(1):79-88. doi: 10.1016/s0022-1759(97)00110-5. J Immunol Methods. 1997. PMID: 9328589
Therapeutic potential of AGE inhibitors and breakers of AGE protein cross-links.
Vasan S, Foiles PG, Founds HW. Vasan S, et al. Among authors: founds hw. Expert Opin Investig Drugs. 2001 Nov;10(11):1977-87. doi: 10.1517/13543784.10.11.1977. Expert Opin Investig Drugs. 2001. PMID: 11772301 Review.
Inhibition of advanced glycation endproduct formation by acetaldehyde: role in the cardioprotective effect of ethanol.
Al-Abed Y, Mitsuhashi T, Li H, Lawson JA, FitzGerald GA, Founds H, Donnelly T, Cerami A, Ulrich P, Bucala R. Al-Abed Y, et al. Among authors: founds h. Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2385-90. doi: 10.1073/pnas.96.5.2385. Proc Natl Acad Sci U S A. 1999. PMID: 10051651 Free PMC article.
Tobacco smoke is a source of toxic reactive glycation products.
Cerami C, Founds H, Nicholl I, Mitsuhashi T, Giordano D, Vanpatten S, Lee A, Al-Abed Y, Vlassara H, Bucala R, Cerami A. Cerami C, et al. Among authors: founds h. Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13915-20. doi: 10.1073/pnas.94.25.13915. Proc Natl Acad Sci U S A. 1997. PMID: 9391127 Free PMC article.
Long-term assessment of glucose control by haemoglobin-AGE measurement.
Wolffenbuttel BH, Giordano D, Founds HW, Bucala R. Wolffenbuttel BH, et al. Among authors: founds hw. Lancet. 1996 Feb 24;347(9000):513-5. doi: 10.1016/s0140-6736(96)91141-1. Lancet. 1996. PMID: 8596270
Reduction of plasma apolipoprotein-B by effective removal of circulating glycation derivatives in uremia.
Fishbane S, Bucala R, Pereira BJ, Founds H, Vlassara H. Fishbane S, et al. Among authors: founds h. Kidney Int. 1997 Dec;52(6):1645-50. doi: 10.1038/ki.1997.497. Kidney Int. 1997. PMID: 9407512 Free article. Clinical Trial.
Serum advanced glycosylation end-products in patients on hemodialysis and CAPD.
Ateshkadi A, Johnson CA, Founds HW, Zimmerman SW. Ateshkadi A, et al. Among authors: founds hw. Perit Dial Int. 1995;15(2):129-33. Perit Dial Int. 1995. PMID: 7612732 Clinical Trial.
13 results
Jump to page